EVIDENT and Ultivue: Collaboration provides a convenient, fast tool for multiplexed immunofluorescence imaging in translational studies WALTHAM and CAMBRIDGE, Mass., (Nov. 7, 2022)–Evident Corporation, a premier manufacturer of life science imaging systems, and Ultivue, Inc., an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, announced a collaborative agreement to promote […]
The post EVIDENT and Ultivue Collaborate to Advance Multiplex Slide Imaging and Spatial Analysis in Translational Research first appeared on Tissuepathology.com.